反应条件
1.1: salicylic acid; selenium(IV) oxide; tert.-butylhydroperoxide / water; dichloromethane / 24 h / 0 - 20 °C 2.1: sodium tetrahydroborate / methanol; tetrahydrofuran / 0.75 h / -10 °C 3.1: phosphorus tribromide / tetrahydrofuran / 3 h / 0 °C / |Inert atmosphere 4.1: N,N-dimethyl-formamide / 18 h / 20 °C / |Darkness 5.1: potassium tert-butylate / tetrahydrofuran; N,N-dimethyl-formamide / 2.67 h / -78 °C 5.2: -78 - 20 °C 6.1: sodium hydroxide; water / methanol / 1 h / 20 °C / pH 12 7.1: phosphorus tribromide / tetrahydrofuran / 0.5 h / 0 °C / |Inert atmosphere; |Cooling with acetone-dry ice 8.1: sodium hexamethyldisilazane / tetrahydrofuran; N,N-dimethyl-formamide / 0.5 h / -20 - 0 °C / |Inert atmosphere; |Cooling with acetone-dry ice 9.1: Pd(1,2-bis(diphenylphosphino)ethane)Cl2 / tetrahydrofuran / 0.08 h / 0 °C / |Cooling with acetone-dry ice; |Inert atmosphere 9.2: 4.5 h / 0 °C / |Inert atmosphere 10.1: ammonium cerium (IV) nitrate / water; dichloromethane; acetonitrile / 0.25 h / 0 °C View Scheme
参考文献
INSTYTUT FARMACEUTYCZNY; VitaSynth Sp. z.o.o.; KRAJEWSKI, Krzysztof; KUTNER, Andrzej; DZIKOWSKA, Jadwiga; GUTOWSKA, Jadwiga; NAPIÓRKOWSKI, Marek; WINIARSKI, Jerzy; KUBISZEWSKI, Marek; JEDYNAK, Łukasz; MORZYCKI, Jacek; WITKOWSKI, Stanisław; BAJ, Aneta; WAŁEJKO, Piotr
Patent: WO2014/58330 A2, 2014 ;